Collectively, these results suggest that Dvl2 can decrease the expression of inflammatory cytokine and anti-apoptosis genes by inhibiting the NF-κB pathway in human primary RA-FLSs (Figure 6E). The gene discussed is NFKB1; the disease is rheumatoid arthritis.